Therefore, the present data suggests that for this pancreatic cancer cohort, EGFR, ERK1, ERK2, c-Jun, and c-Fos transcript levels are not gender-dependent (Figure 3C). This evidence concerns the gene MAPK3 and pancreatic neoplasm.